IMGC936

· ImmunoGen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMGC936, covering 2025-01-15 to 2025-01-15. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Study of IMGC936 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]